Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Cervical Cancer

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 80 articles: HTML format

Single Articles

June 2008
1. VAN DER AA MA , de Kok IM, Siesling S, van Ballegooijen M, et al
   Does lowering the screening age for cervical cancer in The Netherlands make sense?
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   May 2008
2. SANTEGOETS LA , van Seters M, Heijmans-Antonissen C, Kleinjan A, et al
   Reduced local immunity in HPV-related VIN: Expression of chemokines and involvement of immunocompetent cells.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. GLATT S , Halbauer D, Heindl S, Wernitznig A, et al
   hGPR87 contributes to viability of human tumor cells.
   Int J Cancer. 2008;122:2008-16.
   PubMed     Related articles    Abstract available
   
   
   April 2008
4. HUSSAIN SK , Sundquist J, Hemminki K
   Familial clustering of cancer at human papillomavirus-associated sites according to the Swedish Family-Cancer Database.
   Int J Cancer. 2008;122:1873-8.
   PubMed     Related articles    Abstract available
   
   
   
5. ARBYN M , Sankaranarayanan R, Muwonge R, Keita N, et al
   Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. VAN DEN HENDE M , van Poelgeest MI, van der Hulst JM, de Jong J, et al
   Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. LAI HC , Lin YW, Huang TH, Yan P, et al
   Identification of novel DNA methylation markers in cervical cancer.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. WAN F , Miao X, Quraishi I, Kennedy V, et al
   Gene expression changes during HPV-mediated carcinogenesis: A comparison between an in vitro cell model and cervical cancer.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. ENGELS EA , Biggar RJ, Hall HI, Cross H, et al
   Cancer risk in people infected with human immunodeficiency virus in the United States.
   Int J Cancer. 2008;123:187-194.
   PubMed     Related articles    Abstract available
   
   
   
10. CLIFFORD G , Franceschi S
    Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix.
    Int J Cancer. 2008;122:1684-5.
    PubMed     Related articles   
    
    
    March 2008
11. PEREZ G , Lazcano-Ponce E, Hernandez-Avila M, Garcia PJ, et al
    Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women.
    Int J Cancer. 2008;122:1311-8.
    PubMed     Related articles    Abstract available
    
    
    
12. CHAO A , Hsu KH, Lai CH, Huang HJ, et al
    Cervical cancer screening program integrating Pap smear and HPV DNA testing: A population-based study.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
13. FRANCESCHI S , Clifford GM
    Fraction of cervical neoplasias due to human papillomavirus 16 and 18 in vaccine trials.
    Int J Cancer. 2008;122:719-20.
    PubMed     Related articles   
    
    
    January 2008
14. CUZICK J , Szarewski A, Mesher D, Cadman L, et al
    Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. MUJAT C , Greiner C, Baldwin A, Levitt JM, et al
    Endogenous optical biomarkers of normal and human papillomavirus immortalized epithelial cells.
    Int J Cancer. 2008;122:363-71.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
16. PRETET JL , Jacquard AC, Carcopino X, Monnier-Benoit S, et al
    Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study.
    Int J Cancer. 2008;122:424-7.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    December 2007
17. DE BOER MA , Jordanova ES, van Poelgeest MI, van den Akker BE, et al
    Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
    Int J Cancer. 2007;121:2711-5.
    PubMed     Related articles    Abstract available
    
    
    
18. JESS PR , Smith DD, Mazilu M, Dholakia K, et al
    Early detection of cervical neoplasia by Raman spectroscopy.
    Int J Cancer. 2007;121:2723-8.
    PubMed     Related articles    Abstract available
    
    
    
19. KAUFMANN AM , Nieland JD, Jochmus I, Baur S, et al
    Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).
    Int J Cancer. 2007;121:2794-800.
    PubMed     Related articles    Abstract available
    
    
    
20. CASTELLSAGUE X , Klaustermeier J, Carrilho C, Albero G, et al
    Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: Burden and potential for prevention.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
21. VAN DER AA MA , Pukkala E, Coebergh JW, Anttila A, et al
    Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
22. DE WILDE J , Wilting SM, Meijer CJ, van de Wiel MA, et al
    Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
23. PIERSMA SJ , Welters MJ, van der Hulst JM, Kloth JN, et al
    Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. MOLLING JW , de Gruijl TD, Glim J, Moreno M, et al
    CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia.
    Int J Cancer. 2007;121:1749-55.
    PubMed     Related articles    Abstract available
    
    
    
25. BISTOLETTI P , Sennfalt K, Dillner J
    Cost-effectiveness of primary cytology and HPV DNA cervical screening.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
26. REBOLJ M , Bais AG, van Ballegooijen M, Boer R, et al
    Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies.
    Int J Cancer. 2007;121:1529-35.
    PubMed     Related articles    Abstract available
    
    
    September 2007
27. PRETET JL , Jacquard AC, Carcopino X, Charlot JF, et al
    Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
28. WU RF , Dai M, Qiao YL, Clifford GM, et al
    Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation.
    Int J Cancer. 2007;121:1306-11.
    PubMed     Related articles    Abstract available
    
    
    August 2007
29. DE VUYST H , Gichangi P, Estambale B, Njuguna E, et al
    Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. SIGURDSSON K , Taddeo FJ, Benediktsdottir KR, Olafsdottir K, et al
    HPV genotypes in CIN 2-3 lesions and cervical cancer: A population-based study.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
31. GIORGI-ROSSI P , Segnan N, Zappa M, Naldoni C, et al
    The impact of new technologies in cervical cancer screening: Results of the recruitment phase of a large randomised controlled trial from a public health perspective.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
32. GRAVITT PE , Kovacic MB, Herrero R, Schiffman M, et al
    High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. SHIN HR , Park S, Hwang SY, Kim JE, et al
    Trends in cervical cancer mortality in korea 1993-2002: Corrected mortality using national death certification data and national cancer incidence data.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
34. KHOUADRI S , Villa LL, Gagnon S, Koushik A, et al
    Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. LUNDQVIST E , Kaprio J, Verkasalo PK, Pukkala E, et al
    Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins.
    Int J Cancer. 2007;121:810-8.
    PubMed     Related articles    Abstract available
    
    
    
36. IVANSSON EL , Gustavsson IM, Magnusson JJ, Steiner LL, et al
    Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
37. PRETORIUS RG , Bao YP, Belinson JL, Burchette RJ, et al
    Inappropriate gold standard bias in cervical cancer screening studies.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. BAALBERGEN A , Ewing-Graham PC, Eijkemans MJ, Helmerhorst TJ, et al
    Prognosis of adenocarcinoma of the uterine cervix: p53 expression correlates with higher incidence of mortality.
    Int J Cancer. 2007;121:106-10.
    PubMed     Related articles    Abstract available
    
    
    June 2007
39. CHANG HS , Lin CH, Yang CH, Yen MS, et al
    Increased expression of Dyrk1a in HPV16 immortalized keratinocytes enable evasion of apoptosis.
    Int J Cancer. 2007;120:2377-85.
    PubMed     Related articles    Abstract available
    
    
    May 2007
40. MIYATAKE T , Ueda Y, Nakashima R, Yoshino K, et al
    Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): novel marker for cervical carcinogenesis.
    Int J Cancer. 2007;120:2068-77.
    PubMed     Related articles    Abstract available
    
    
    
41. BACHMANN A , Zawatzky R, Rosl F
    Genetic redundancy in human cervical carcinoma cells: identification of cells with "normal" properties.
    Int J Cancer. 2007;120:2119-26.
    PubMed     Related articles    Abstract available
    
    
    
42. MARTIN SF , Wood AD, McRobbie MM, Mazilu M, et al
    Fluorescence spectroscopy of an in vitro model of human cervical precancer identifies neoplastic phenotype.
    Int J Cancer. 2007;120:1964-70.
    PubMed     Related articles    Abstract available
    
    
    April 2007
43. ALMONTE M , Ferreccio C, Winkler JL, Cuzick J, et al
    Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. SONG XH , Liang B, Liu GF, Li R, et al
    Expression of a novel alternatively spliced variant of NADP(H)-dependent retinol dehydrogenase/reductase with deletion of exon 3 in cervical squamous carcinoma.
    Int J Cancer. 2007;120:1618-26.
    PubMed     Related articles    Abstract available
    
    
    
45. SICHERO L , Ferreira S, Trottier H, Duarte-Franco E, et al
    High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18.
    Int J Cancer. 2007;120:1763-8.
    PubMed     Related articles    Abstract available
    
    
    
46. SMITH JS , Lindsay L, Hoots B, Keys J, et al
    Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
47. BAIS AG , van Kemenade FJ, Berkhof J, Verheijen RH, et al
    Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs.
    Int J Cancer. 2007;120:1505-10.
    PubMed     Related articles    Abstract available
    
    
    March 2007
48. BULK S , Bulkmans NW, Berkhof J, Rozendaal L, et al
    Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
49. BERRINGTON DE GONZALEZ A , Green J
    Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studi
    Int J Cancer. 2007;120:885-91.
    PubMed     Related articles    Abstract available
    
    
    
50. MAO C , Balasubramanian A, Yu M, Kiviat N, et al
    Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: Results from proof-of-concept study.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. MORISHIMA S , Akatsuka Y, Nawa A, Kondo E, et al
    Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: the combined effects of bortezomib and interferon-gamma on the presentation of a cryptic epitope.
    Int J Cancer. 2007;120:594-604.
    PubMed     Related articles    Abstract available
    
    
    January 2007
52. HAFNER N , Gajda M, Altgassen C, Hertel H, et al
    HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
53. LAI CH , Huang HJ, Hsueh S, Chao A, et al
    Human papillomavirus genotype in cervical cancer: A population-based study.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. HOWLETT RI , Marrett LD, Innes MK, Rosen BP, et al
    Decreasing incidence of cervical adenocarcinoma in Ontario: is this related to improved endocervical Pap test sampling?
    Int J Cancer. 2007;120:362-7.
    PubMed     Related articles    Abstract available
    
    
    
55. EINSTEIN MH , Studentsov YY, Ho GY, Fazzari M, et al
    Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia.
    Int J Cancer. 2007;120:55-9.
    PubMed     Related articles    Abstract available
    
    
    December 2006
56. VON KNEBEL DOEBERITZ M
    The dawn of prophylactic vaccines against human papillomaviruses and cervical cancer.
    Int J Cancer. 2006;119:xi-xii.
    PubMed     Related articles   
    
    
    
57. 
    Spotlight on papillomaviruses.
    Int J Cancer. 2006;119:ix.
    PubMed     Related articles   
    
    
    
58. COUTO E , Hemminki K
    Heritable and environmental components in cervical tumors.
    Int J Cancer. 2006;119:2699-701.
    PubMed     Related articles    Abstract available
    
    
    November 2006
59. REBOLJ M , van Ballegooijen M, Berkers LM, Habbema D, et al
    Monitoring a national cancer prevention program: Successful changes in cervical cancer screening in the netherlands.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
60. LOCKWOOD WW , Coe BP, Williams AC, Macaulay C, et al
    Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
61. MADELEINE MM , Anttila T, Schwartz SM, Saikku P, et al
    Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
62. ZHANG Q , Kuhn L, Denny LA, De Souza M, et al
    Impact of utilizing p16(INK4A) immunohistochemistry on estimated performance of three cervical cancer screening tests.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
63. WISMAN GB , Nijhuis ER, Hoque MO, Reesink-Peters N, et al
    Assessment of gene promoter hypermethylation for detection of cervical neoplasia.
    Int J Cancer. 2006;119:1908-14.
    PubMed     Related articles    Abstract available
    
    
    July 2006
64. BOS AB , Rebolj M, Habbema JD, van Ballegooijen M, et al
    Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
65. LAGE H , Aki-Sener E, Yalcin I
    High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs.
    Int J Cancer. 2006;119:213-20.
    PubMed     Related articles    Abstract available
    
    
    June 2006
66. SIER CF , Zuidwijk K, Zijlmans HJ, Hanemaaijer R, et al
    EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma.
    Int J Cancer. 2006;118:2991-8.
    PubMed     Related articles    Abstract available
    
    
    May 2006
67. IVANSSON EL , Rasmussen F, Gyllensten UB, Magnusson PK, et al
    Reduced incidence of cervical cancer in mothers of sons with allergic rhinoconjunctivitis, asthma or eczema.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
68. MCCARTHY C , Youde SJ, Man S
    Definition of an HPV18/45 cross-reactive human T-cell epitope after DNA immunisation of HLA-A2/KB transgenic mice.
    Int J Cancer. 2006;118:2514-21.
    PubMed     Related articles    Abstract available
    
    
    
69. VISSER J , van Baarle D, Hoogeboom BN, Reesink N, et al
    Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia.
    Int J Cancer. 2006;118:2529-37.
    PubMed     Related articles    Abstract available
    
    
    April 2006
70. SANGWA-LUGOMA G , Mahmud S, Nasr SH, Liaras J, et al
    Visual inspection as a cervical cancer screening method in a primary health care setting in Africa.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
71. CUZICK J , Clavel C, Petry KU, Meijer CJ, et al
    Overview of the European and North American studies on HPV testing in primary cervical cancer screening.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
72. BERKHOF J , de Bruijne MC, Zielinski GD, Bulkmans NW, et al
    Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis.
    Int J Cancer. 2006;118:1759-68.
    PubMed     Related articles    Abstract available
    
    
    March 2006
73. MAYRAND MH , Duarte-Franco E, Coutlee F, Rodrigues I, et al
    Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
74. SNIJDERS PJ , Hogewoning CJ, Hesselink AT, Berkhof J, et al
    Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
75. 
    Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
76. APPLEBY P , Beral V, Berrington de Gonzalez A, Colin D, et al
    Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies.
    Int J Cancer. 2006;118:1481-95.
    PubMed     Related articles    Abstract available
    
    
    January 2006
77. CHAO A , Wang TH, Lee YS, Hsueh S, et al
    Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    December 2005
78. KANG S , Kim JW, Kang GH, Lee S, et al
    Comparison of DNA hypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.
    Int J Cancer 2005;.
    PubMed     Related articles    Abstract available
    
    
    November 2005
79. BERTELSEN BI , Steine SJ, Sandvei R, Molven A, et al
    Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: Frequent PIK3CA amplification and AKT phosphorylation.
    Int J Cancer 2005;.
    PubMed     Related articles    Abstract available
    
    
    October 2005
80. CHAN PK , Cheung JL, Cheung TH, Lin CK, et al
    HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women.
    Int J Cancer 2005;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: